September 2026
September 2, 2026
New KRAS Inhibitors Show Promise in Treating NF1 Tumors
A breakthrough in treating neurofibromatosis type 1 (NF1) has been reported by Nancy Ratner, Ph.D., and her team, who found that new KRAS inhibitors may…